The psychedelic drugs market was valued at $0.7 billion in 2022 and is projected to reach $2.6 billion by 2032, growing at a CAGR of 13.4% from 2023 to 2032.
Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) has been given a consensus rating of “Buy” by the six analysts that are currently covering the stock, Ratings reports. Six analysts have ...
General Manager for Research Development and Adoption at MLA ... has been on the ground working together with Indonesian feedlots to implement important biosecurity measures since the incursion of LSD ...
A groundbreaking study has revealed that the brain waves of humans and dogs synchronize during social interactions, deepening our understanding of the strong bond shared between these two species.
Psychedelics and hallucinogens include a wide variety of substances, including LSD, psylocibin (mushrooms), MDMA (molly), ketamine, mescaline, DMT and more.